ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,068,000 | +1.4% | 13,905 | -1.2% | 0.01% | -7.1% |
| Q3 2020 | $1,053,000 | -72.8% | 14,071 | -77.1% | 0.01% | -74.1% |
| Q2 2020 | $3,874,000 | +45.6% | 61,535 | -2.8% | 0.05% | +28.6% |
| Q1 2020 | $2,661,000 | -9.1% | 63,335 | 0.0% | 0.04% | +44.8% |
| Q4 2019 | $2,929,000 | +0.8% | 63,335 | -0.2% | 0.03% | -9.4% |
| Q3 2019 | $2,906,000 | -21.9% | 63,485 | 0.0% | 0.03% | -20.0% |
| Q2 2019 | $3,723,000 | +178.5% | 63,485 | +113.0% | 0.04% | +166.7% |
| Q1 2019 | $1,337,000 | +24.5% | 29,804 | +8.1% | 0.02% | +7.1% |
| Q4 2018 | $1,074,000 | -15.3% | 27,560 | 0.0% | 0.01% | +16.7% |
| Q3 2018 | $1,268,000 | +5.5% | 27,560 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $1,202,000 | +8.1% | 27,560 | -2.1% | 0.01% | +9.1% |
| Q1 2018 | $1,112,000 | +5.7% | 28,145 | -9.1% | 0.01% | +10.0% |
| Q4 2017 | $1,052,000 | +33.3% | 30,956 | 0.0% | 0.01% | +66.7% |
| Q3 2017 | $789,000 | – | 30,956 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 505,670 | $34,487,000 | 7.23% |
| Asymmetry Capital Management, L.P. | 142,246 | $9,701,000 | 6.67% |
| Prosight Management, LP | 137,000 | $9,343,000 | 5.84% |
| Avoro Capital Advisors LLC | 4,075,000 | $277,915,000 | 4.84% |
| Integral Health Asset Management, LLC | 225,000 | $15,345,000 | 4.22% |
| First Light Asset Management, LLC | 617,124 | $42,088,000 | 2.52% |
| SECTORAL ASSET MANAGEMENT INC | 322,599 | $22,001,000 | 1.78% |
| Avidity Partners Management LP | 943,000 | $64,313,000 | 1.74% |
| DAFNA Capital Management LLC | 119,615 | $8,158,000 | 1.71% |
| Nicholas Investment Partners, LP | 298,247 | $20,340,000 | 1.28% |